RAS-mutant Colorectal Cancer

Who we are

  • March 28, 2025
    SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.